{"url_path":"/sec/sonm/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024644-index.html","accession_number":"0001493152-26-024644","cik":"0001178697","ticker":"SONM","issuer_name":"DNA X, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024644-index.html","primary_entity_key":"0001178697","primary_entity_name":"DNA X, Inc."},"word_count":41,"has_tables":true,"body_markdown":"**Item\n5. Other Information.**\n\n \n\nNone\nof our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined\nin Item 408(c) of Regulation S-K) during the quarterly period covered by this report.\n\n \n\n31"}